These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Infallible measures needed to prevent errors in the administration of chemotherapeutic agents. Anderson RA; Wolff JE; Egeler RM; Coppes MJ Med Pediatr Oncol; 1999 May; 32(5):401-2. PubMed ID: 10219350 [No Abstract] [Full Text] [Related]
24. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report. Qweider M; Gilsbach JM; Rohde V J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029 [TBL] [Abstract][Full Text] [Related]
25. Safe vincristine use in Switzerland: Still a long way to go? Brühwiler LD; Schwappach DL J Oncol Pharm Pract; 2020 Jan; 26(1):51-59. PubMed ID: 30866715 [TBL] [Abstract][Full Text] [Related]
32. The time has come for non-interchangeability of spinal and epidural equipment with intravascular access ports. Laws D Br J Anaesth; 2001 Jun; 86(6):903. PubMed ID: 11573614 [No Abstract] [Full Text] [Related]
33. Accidental intraventricular vincristine administration: an avoidable iatrogenic death. Lau G Med Sci Law; 1996 Jul; 36(3):263-5. PubMed ID: 8918096 [TBL] [Abstract][Full Text] [Related]
34. Medical misadventure = human tragedy. Turner P; Thornton N Axone; 2001 Jun; 22(4):30-5. PubMed ID: 14621503 [TBL] [Abstract][Full Text] [Related]
36. Promoting safe use of vincristine sulfate. Slimowitz R Am J Hosp Pharm; 1992 Aug; 49(8):1908, 1910. PubMed ID: 1442830 [No Abstract] [Full Text] [Related]
37. Introduction of vincristine mini-bags and an assessment of the subsequent risk of extravasation. Nurgat ZA; Smythe M; Al-Jedai A; Ewing S; Rasheed W; Belgaumi A; Ahmed SO; Ashour M; Al Agil A; Siddiqui K; Aljurf M J Oncol Pharm Pract; 2015 Oct; 21(5):339-47. PubMed ID: 24821691 [TBL] [Abstract][Full Text] [Related]